by Corina Milic | Sep 12, 2018
CHAI’s HIV Market Report provides a global perspective on the ARV marketplace in low- and middle-income countries in 2017 and outlines CHAI’s expectations on how the market will evolve over the next five years. Read the report here: 2018 HIV Market...
by Corina Milic | Jun 21, 2018
Introducing the second edition of CHAI’s HIV Mid-Year Market Memo, an informational brief that covers the latest trends in the HIV space in low- and middle-income countries (LMICs) since the publication of CHAI’s annual ARV Market Report in September 2017. See the HIV...
by Corina Milic | Apr 23, 2018
As low- and middle-income countries (LMICs) set their sights on the global elimination of hepatitis C virus (HCV) by 2030, adoption of WHO recommendations for diagnosis and improved access to testing will be critical. We believe that better market intelligence will...
by Corina Milic | Dec 22, 2017
CHAI supports national governments to expand high-quality care and treatment to people living with HIV/AIDS. CHAI negotiates reduced prices for antiretroviral (ARVs) on behalf of members of its procurement consortium. See the 2017 CHAI ARV Reference Price List...
by Corina Milic | Dec 1, 2017
Years of experience show that licensing is highly effective for ensuring that many more people in developing countries can access life-saving HIV medicines. CHAI and Access to Medicine Foundation have published a paper outlining best practice licensing models that...
by Corina Milic | Oct 18, 2017
In 2019, updates to historical datasets were made upon consultation with relevant current suppliers, including the addition of a new supplier’s data. Please find the most up-to-date report here. The 2017 Family Planning Market Report can be found below. Download...
